Skip to main content
Premium Trial:

Request an Annual Quote

Impact Lab Group Acquires Toma Advanced Biomedical Assays Services Lab

NEW YORK (GenomeWeb) – Italian oncology genetics company Impact Lab Group announced yesterday that it has acquired Toma Advanced Biomedical Assays Services Lab for an undisclosed amount.

Toma — which is headquartered in Busto Arsizio, Italy — specializes in cytogenetics, molecular biology, and prenatal diagnostics, including research on reproductive diseases. Its merger with Milan-based Impact Lab will create the largest research and genetics laboratory in Italy, the companies said.

Through the acquisition, Impact Lab will combine its expertise with Toma's lab services portfolio to provide clinically and scientifically annotated biospecimens, as well as gene sequencing, bioinformatics, and laboratory services to the worldwide diagnostics industries, hospitals, and private clinicians.

Impact Lab Founder and Managing Director Vittorio Grazioli will become Toma's managing director, while Toma Chairman Federico Maggi will continue in his role. Francesca Romana Grati has been named scientific and clinical director.

"Today marks a crucial step forward for the large international project launched by Impact Lab three years ago to create the most important diagnostics center in Europe," Grazioli said in a statement. "Toma is one of the largest global genetic laboratories in the world and its database has been used for many scientific publications, diagnostic products, and process validations. [It is also] an international landmark for all the scientists operating on the pre- and post-natal field. It is our desire to maintain this reputation and continue the scientific research."

Over the next five years, the combined company is expected to significantly increase its presence in the Italian market and to improve its connections in the Mediterranean region.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.